According to Decision Advisors, the Global Lung cancer screening software Market Size is expected to grow from USD 1.475 billion in 2024 to USD 5.38 billion by 2035, at a CAGR of 13.81% during the forecast period 2025-2035. Global lung cancer screening software market is expected to experience substantial growth over the forecast period due primarily to growing use of AI in diagnostics, a rise in diagnostic tests for lung cancer, and worldwide increases in early lung cancer detection programs. The global AI-based diagnostic tools market will expand due to advances in imaging technologies; increased digitalization of healthcare; and continued investments in lung cancer screening programs.

According to Decision Advisors, the Global Lung cancer screening software Market Size is expected to grow from USD 1.475 billion in 2024 to USD 5.38 billion by 2035, at a CAGR of 13.81% during the forecast period 2025-2035. Global lung cancer screening software market is expected to experience substantial growth over the forecast period due primarily to growing use of AI in diagnostics, a rise in diagnostic tests for lung cancer, and worldwide increases in early lung cancer detection programs. The global AI-based diagnostic tools market will expand due to advances in imaging technologies; increased digitalization of healthcare; and continued investments in lung cancer screening programs.